User menu

Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study.

Bibliographic reference Vuylsteke, Peter ; Huizing, M ; Petrakova, K ; Roylance, R ; Laing, R ; et. al. Pictilisib PI3Kinase inhibitor (a phosphatidylinositol 3-kinase [PI3K] inhibitor) plus paclitaxel for the treatment of hormone receptor-positive, HER2-negative, locally recurrent, or metastatic breast cancer: interim analysis of the multicentre, placebo-controlled, phase II randomised PEGGY study.. In: Annals of Oncology, Vol. 27, p. 2059-2066 (2016)
Permanent URL http://hdl.handle.net/2078.1/192204